Hospira, Inc.
275 N. Field Drive
Lake Forest IL 60045 United States
Phone: 224-212-2000
Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness™. As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps
improve the safety, cost and productivity of patient care.
HEADQUARTERS Lake Forest, Ill.
EMPLOYEES Approximately 13,500 employees worldwide
OPERATIONS Seven manufacturing facilities in the United States include: Austin, Texas;
Boulder, Colo.; Buffalo, N.Y.; Clayton, N.C.; McPherson, Kan.; Morgan Hill, Calif.; and Rocky Mount, N.C. Six facilities outside the United States include: Haina, Dominican Republic; La Aurora de Heredia, Costa Rica; Liscate, Italy; Mulgrave, Australia; Sligo,
Ireland; and Zagreb, Croatia
MAJOR BUSINESSES/PRODUCTS
Hospira has a leading position in the manufacture and supply of a broad range of
Specialty injectables (generic acute-care and oncology injectables,intensive-care proprietary pharmaceuticals and biogenerics [including Retacrit™ in Europe], as well as proprietary delivery systems such as the
iSecure™ syringe, a pre-filled, ready-to-use, disposable syringe)Medication management systems (electronic infusion pumps, such as the
Symbiq™, Plum A+™, LifeCare PCA™ and GemStar™ product lines; Hospira MedNet™ safety software; and clinical decision support tools, such as EndoTool™ glucose management system, VeriScan™ Rx bar code point-of-care
system and TheraDoc's Control Assisant™ and TheraDoc Antibiotic Assistant™ )
Infusion therapy solutions/supplies (including the VisIV™ next-generation container)
Third-party contract manufacturing, which leverages Hospira's expertise in pharmaceutical manufacturing.
|
Email: corporate.staffing@hospira.com
Ownership: Public
Website: Hospira, Inc.
Symbol:
Stock Exchange:
Industry: Big Pharma
Segment: Biopharmaceuticals
|
|